This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet), Inis Biotech LLC. Active years: 2016.
Company Filing History:
1 out of 81 
1 out of 20 
Years Active: 2016
Title: The Innovative Contributions of Andres E Ibanez
Introduction
Andres E Ibanez is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of vaccine development, particularly through his innovative patent related to adjuvants for vaccines. His work has implications for enhancing vaccine efficacy and safety.
Latest Patents
Andres E Ibanez holds a patent titled "Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof." This patent describes an adjuvant that comprises a non-lipidated bacterial outer-membrane polypeptide (Omp). The bacteria may belong to various genera. The adjuvant can be a modified polypeptide or specifically the Omp19S or Omp16S polypeptides, or mixtures thereof. In preferred embodiments, the adjuvant includes the non-lipidated polypeptide found in SEQ ID No: 1 or SEQ ID No: 2, or parts thereof. This innovation is crucial for improving vaccine formulations.
Career Highlights
Throughout his career, Andres E Ibanez has worked with esteemed organizations such as the Consejo Nacional de Investigaciones Científicas y Técnicas (Conicet) and Inis Biotech LLC. His experience in these institutions has allowed him to contribute to significant advancements in biotechnology and vaccine research.
Collaborations
Andres has collaborated with notable colleagues, including Mirta L Coria and Karina A Pasquevich. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of vaccines.
Conclusion
Andres E Ibanez is a prominent figure in vaccine innovation, with a patent that showcases his expertise in developing effective adjuvants. His contributions are vital for the advancement of vaccine technology and public health.